AKT1 and Alzheimer disease: Dysregulation of the PI3K/Akt pathway occurs at multiple levels in AD and extends beyond Nrf2 signaling, as oligomeric amyloid-beta peptides can activate PI3K/Akt and the mTORC1 pathway.